With Ropren delayed indefinitely, and capital raising just around the corner, the directors are doing whatever they can to mop up the sellers. I want to thank them for doing a fantastic job.
I hope the capital raising is not at too steep a discount to the prevailing market price. No more than a 20% discount will be a good result for us.